Serum anti-PLA2R antibody and glomerular PLA2R deposition in Chinese patients with membranous nephropathy: a cross-sectional study

L Pang, AM Zhang, HX Li, JL Du, LL Jiao, N Duan… - Medicine, 2017 - journals.lww.com
M-type phospholipase A2 receptor (PLA2R) is the major target antigen in primary
membranous nephropathy (PMN). Previous studies have evaluated the diagnostic value of …

Anti-phospholipase A2 receptor (PLA2R) antibody and glomerular PLA2R expression in Japanese patients with membranous nephropathy

K Hihara, M Iyoda, S Tachibana, K Iseri, T Saito… - PLoS …, 2016 - journals.plos.org
The phospholipase A2 receptor (PLA2R) is the major target antigen (Ag) in idiopathic
membranous nephropathy (IMN). Recently, several types of immunoassay systems for anti …

Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese

N Hayashi, S Akiyama, H Okuyama, Y Matsui… - Clinical and …, 2015 - Springer
Background Recent studies have suggested that assessments of serum antibodies against
M-type phospholipase A2 receptor (PLA2R) and the glomerular expression of PLA2R …

Serum anti-PLA2R antibody predicts treatment outcome in idiopathic membranous nephropathy

SY Wei, YX Wang, JS Li, SL Zhao, TT Diao… - American Journal of …, 2016 - karger.com
Background: M-type phospholipase A 2 receptor (PLA 2 R) has been identified as the major
target antigen in idiopathic membranous nephropathy (IMN). However, the role of …

[HTML][HTML] Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy

EJ Song, KH Jeong, YA Yang, JH Lim… - Kidney research and …, 2018 - ncbi.nlm.nih.gov
Background Phospholipase A2 receptor (PLA2R) has been identified as a major
autoantigen in primary membranous nephropathy (MN). We evaluated the association …

[HTML][HTML] Anti-phospholipase A2 receptor (Anti-PLA2R) antibody in diagnosis and treatment of idiopathic membranous nephropathy: a single-center observational …

N Guo, Y Cao, H Dai, L Yuan, L Shi… - Medical Science Monitor …, 2019 - ncbi.nlm.nih.gov
Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of
Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China - PMC Back …

Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA

H Kaga, A Komatsuda, S Yamamoto, T Kikuchi… - Clinical and …, 2019 - Springer
Background The prevalence of antibodies against M-type anti-phospholipase A2 receptor
(PLA2R) was reported to be~ 70–80% in early studies on idiopathic membranous …

Serum anti-PLA2R antibody as a diagnostic biomarker of idiopathic membranous nephropathy: the optimal cut-off value for Chinese patients

Y Liu, X Li, C Ma, P Wang, J Liu, H Su, H Zhuo… - Clinica Chimica …, 2018 - Elsevier
Background The M-type phospholipase A2 receptor (PLA2R) is a specific target autoantigen
identified in idiopathic membranous nephropathy (IMN). The autoantibody against PLA2R …

Seropositive PLA2R-associated membranous nephropathy but biopsy-negative PLA2R staining

J Luo, W Zhang, C Su, Z Zhou… - Nephrology Dialysis …, 2021 - academic.oup.com
Background Serum phospholipase A2 receptor (PLA2R) antibody (SAb) and glomerular
deposits of PLA2R antigen (GAg) have been tested widely in idiopathic membranous …

Relationship between renal tissues phospholipase A2 receptor and its serum antibody and clinical condition and prognosis of idiopathic membranous nephropathy: a …

D Dong, T Fan, Y Wang, L Zhang, L Song, L Zhang - BMC nephrology, 2019 - Springer
Objective To investigate the correlation of M-type phospholipase A2 receptor (PLA2R)
expression and serum anti-PLA2R antibody with the clinical parameters and prognosis of …